Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country

Journal of the American Medical Association

Volumn 282, Issue 7, 1999, Pages 677-686

  Dye, Christopher ^a   Scheele, Suzanne ^a   Dolin, Paul ^a   Pathania, Vikram ^a   Raviglione, Mario C ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SUPERINFECTION; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; AIDS RELATED COMPLEX; COST OF ILLNESS; HEALTH; HEALTH SURVEY; INFECTION CONTROL; RISK; STATISTICS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; COST OF ILLNESS; DISEASE NOTIFICATION; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; PREVALENCE; RISK; STATISTICS; TUBERCULOSIS; WORLD HEALTH;

EID: 0033581124     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.7.677     Document Type: Article

References (37)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72:213-220.
2. Murray CJL, Styblo K, Rouillon A. Health sector priorities review: tuberculosis. In: Jamison DT, Mosley WH, eds. Disease Control Priorities in Developing Countries. New York, NY: Oxford University Press; 1993.
3. Murray CJL, Lopez AD. Global Health Statistics, Volume II. Boston, Mass: Harvard School of Public Health; 1996.
4. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70:149-159.
5. World Bank. World Development Report. New York, NY: Oxford University Press; 1993.
6. World Health Organization. Global Tuberculosis Control: WHO Report, 1998. Geneva, Switzerland: World Health Organization; 1998.
7. World Health Organization. Global Tuberculosis Control: WHO Report, 1999. Geneva, Switzerland: World Health Organization; 1999.
8. World Health Organization. WHO Tuberculosis Programme: Framework for Effective TB Control. Geneva, Switzerland: World Health Organization; 1994. Publication WHO/TB/94.179.
9. Barnett GD, Styblo K. Bacteriological and x-ray status of tuberculosis following primary infection acquired during adolescence or later. Bull Int Union Tuberc. 1977;52:5-16.
10. Cauthen GM, Dooley SW, Onorato IM, et al. Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. Am J Epidemiol. 1996;144:69-77.
11. Espinal MA, Reingold AL, Perez G, et al. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:155-159.
12. Githui W, Nunn P, Juma E, et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tuber Lung Dis. 1992;73:203-209.
13. Styblo K. Epidemiology of Tuberculosis. The Hague, the Netherlands: Royal Netherlands Tuberculosis Association; 1991.
14. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40:585-591.
15. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
16. Coronado VG, Beck-Sague CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-1055.
17. Busillo CP, Lessnau KD, Sanjana V, et al. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992;102:797-801.
18. Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc. 1985;60: 117-119.
19. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS. 1997;11(suppl B):S115-S123.
20. Styblo K. State of the art: epidemiology of tuberculosis. Bull Int Union Tuberc. 1978;53:141-148.
21. Hilleboe HE. Post-sanatorium tuberculosis survival rates in Minnesota. Public Health Rep. 1941;56: 895-907.
22. Krebs W. Die Fälle von Lungentuberkulose in der aarganuischen Heilstätte Barmelweid aus den Jahren 1912-1927. Der Aargauischen Heilstätte Barmelweid. 1930:345-379.
23. van den Broek J, Mfinanga S, Moshiro C, O'Brien R, Mugomela A, Lefi M. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. Int J Tuberc Lung Dis. 1998;2:547-552.
24. De Cock KM, Binkin NJ, Zuber PL, Tappero JW, Castro KG. Research issues involving HIV-associated tuberculosis in resource-poor countries. JAMA. 1996; 276:1502-1507.
25. Datta M, Radhamani MP, Selvaraj R, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuber Lung Dis. 1993;74:180-186.
26. Whalen C, Okwera A, Johnson J, et al. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis: the Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med. 1996;153(6 pt 1):1977-1981.
27. World Health Organization. 1996 World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1998.
28. Dye C, Gamett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet. 1998;352:1886-1891.
29. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis. 1995;76:114-121.
30. World Health Organization. Demographic Data for Health Situation Assessment and Projections -1996. Geneva, Switzerland: Division of Health Situation and Trend Assessment; 1996.
31. Cauthen G, Pio A, ten Dam H. Annual Risk of Tuberculosis Infection. Geneva, Switzerland: World Health Organization; 1988. Publication WHO/TB/ 88.154.
32. Ohmori M, Aoki M. Stagnation in the Decline of Tuberculosis Incidence in Japan, and Estimates of Future Incidence Trends: Report of the Tuberculosis Surveillance Research Unit, 1995. The Hague, the Netherlands: Royal Netherlands Tuberculosis Association; 1995.
33. Styblo K, Broekmans JF, Borgdorff M. Expected Decrease in the Tuberculosis Incidence During the Elimination Phase: How to Determine Its Trend? Report of the Tuberculosis Surveillance Research Unit, 1997. The Hague, the Netherlands: Royal Netherlands Tuberculosis Association; 1997.
34. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis. 1996;22:683-704.
35. UNAIDS/World Health Organization. Report on the Global HIV/AIDS Epidemic, June 1998. Geneva, Switzerland: UNAIDS/World Health Organization; 1998.
36. US Bureau of the Census, Population Division, International Programs Center. HIV/AIDS Surveillance Database, January 1997. Washington, DC: United States Bureau of the Census; 1997.
37. Tuberculosis Control Service, Department of Health, Philippines. National Tuberculosis Prevalence Survey, 1997. Manila, Philippines: Dept of Health; 1997.